company

MERMAID BIOVENTURES AS

0263 OSLO

Return on Equity
176,76 %
Current Ratio
1,95
Debt-to-Equity Ratio
0,01
Key figures (NOK)2022
Revenue0
Net Income1 803 000
Total Assets1 851 000
Total Equity1 020 000
Income (NOK)2022
Revenue0
Expenditure80 000
Operating Profit−80 000
Financial Income1 890 000
Financial Costs6 000
Financial Balance1 884 000
Earnings Before Tax1 803 000
Tax0
Net Income1 803 000
Balance (NOK)2022
Total Fixed Assets243 000
Total Current Assets1 608 000
Total Assets1 851 000
Total Retained Equity990 000
Total Equity1 020 000
Total Long-Term Debt7 000
Total Current Debt825 000
Total Equity and Debt1 851 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure80 000
Operating Profit−80 000
Financial Income1 890 000
Financial Costs6 000
Financial Balance1 884 000
Dividends807 000
Net Income1 803 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets243 000
Total Fixed Assets243 000
Stock0
Total Investments0
Cash, Bank801 000
Total Current Assets1 608 000
Total Assets1 851 000
Total Equity1 020 000
Short-Term Group Debt0
Total Long-Term Debt7 000
Creditors0
Unpaid Taxes0
Dividends807 000
Other Current Debt18 000
Total Current Debt825 000
Total Equity and Debt1 851 000
Financial indicators2022
Return on Equity176,76 %
Debt-to-Equity Ratio0,01
Operating Profit Margin-
Current Ratio1,95
Quick Ratio1,95
Equity Ratio0,55
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English